COVID-19 Resources
COVID-19 Resources

To continue supporting our physicians and nurses who are on the front lines of managing the influx of critically ill patients, many of whom will develop acute kidney injury (AKI) or experience renal failure during this pandemic, we have consolidated support resources to help you with providing these patients Continuous Renal Replacement Therapy (CRRT). We will be updating this page with additional support materials as they become available so please check back regularly.

BREAKING NEWS: BAXTER HAS OBTAINED U.S. FDA EMERGENCY USE AUTHORIZATION FOR OXIRIS 3-IN-1 BLOOD FILTER FOR COVID-19 TREATMENT. See more information >

The Role of CRRT in the Fight

Acute kidney injury (AKI) requiring acute renal replacement therapy (RRT) occurs in approximately 15% of all ICU admissions, but this rate is often increased greatly in the setting of severe respiratory failure and acute respiratory distress syndrome (ARDS).

- American Society of Nephrology

Recommendations on the care of hospitalized patients with COVID-19 and kidney failure requiring renal replacement therapy

VIEW ASN GUIDELINES

Now, more than ever, Continuous Renal Replacement Therapy is a critical therapy to be used for patients with AKI requiring renal replacement therapy and especially for those patients who are hemodynamically unstable. It has been reported in various countries that a subset of patients with COVID-19 will become severely ill, with a sepsis like syndrome and multiorgan failure, including acute kidney injury. In these critical cases, CRRT may be a life sustaining and life saving therapy.

- Mary Gellens, MD

Senior Medical Director
Baxter Healthcare Corporation

The current treatment of COVID-19 with AKI includes general and supportive management and kidney replacement therapy. There is no effective antiviral therapy available at present.

- The Novel Coronavirus 2019 epidemic and kidneys.

Kidney International (2020) Article in press. https://doi.org/10.1016/j.kint.2020.03.001

In times of uncertainty, the ability to learn and be proactive makes a huge difference. Our understanding of SARS-CoV-2 prevention and treatment evolves day by day. The clinical characteristics of acute kidney injury (AKI) are heterogeneous and its incidence is reported in up to 25% of patients, some of them requiring renal replacement therapy (RRT). Therefore, preparedness is of utmost importance to maximize our capacity for the provision of RRT. Timely initiation, optimal fluid management and protocolized care with consideration for minimizing healthcare provider exposure should be carefully evaluated.

– Javier A. Neyra, MD, MSCS, FASN

Assistant Professor, Internal Medicine/Nephrology/Bone and Mineral Metabolism Director, Acute Care Nephrology & CRRT Program University of Kentucky Medical Center, Lexington, Kentucky

Baxter Help is Available 24/7

Prismax Prismaflex

THERAPY EDUCATION

Phosphate: The Forgotten Electrolyte:
The kidneys' most important function is the regulation of electrolytes, one of which is phosphorous. Greater than 60% of patients will present with hyperphosphatemia with acute renal failure. Pam Waters discusses how you can help critically ill patients with CRRT therapy.

Download presentation Download PDF 914KB

CRRT: Pre and Post Replacement Solutions - A Guide to Understanding:
Pam Waters, RN, explains the uses and benefits of CRRT replacement solutions, and the differences between pre- and post- replacement solutions.

Download presentation Download PDF 3MB

Managing Patient Temperature During CRRT

Managing Patient Temperature During CRRT
Tena Griffin, DNP, CRNP discusses managing patient blood return temperature including current study data and Baxter's recommendations

Download presentation Download PDF 3MB

TMP and Filter Pressure Drop

TMP and Filter Pressure Drop
Kathy Worthington, MSN, RN discusses factors affecting circuit life, CRRT hemodynamics and troubleshooting tips. 

Download presentation Download PDF 1623KB

Managing Fluid Balance

Fluid Balance in the Critically Ill Patient
Tena will discuss the importance of optimizing patient fluid balance and managing fluid overload in patients with septic shock and acute decompensated heart failure.

Download presentation Download PDF 932KB

CRRT in the Era of Drug Shortages

CRRT in the Era of Drug Shortages
Stephanie Chamberland, RN explains the differences in compounded bags versus commercially available premixed solutions and what can be done to avoid the issues related to drug shortages

Download presentation Download PDF 2MB

PRISMAX SYSTEM TRAINING VIDEOS

PRISMAFLEX SYSTEM TRAINING VIDEOS

Stay Up-to-Date on the Latest News with Our Healthcare Partners

Select a logo below to visit their website for more information.

CDC

NephJC

Society of Critical Care Medicine

American Association of Critical-Care Nurses

ASN

CRRT Online

 
The PRISMAFLEX and PRISMAX Systems are intended for:
Continuous Renal Replacement Therapy (CRRT) for patients weighing 20 kilograms or more with acute renal failure and/or fluid overload.
Therapeutic Plasma Exchange (TPE) therapy for patients weighing 20 kilograms or more with diseases where fluid removal of plasma components is indicated.
Rx Only. For safe and proper use of products mentioned herein refer to the appropriate Instructions for Use or Operator's Manual.

PHOXILLUM and PRISMASOL Renal Replacement Solution Indications and Important Risk Information

Indications and Usage 
PRISMASOL and PHOXILLUM solutions are indicated in pediatric and adult patients for use as a replacement solution in Continuous Renal Replacement Therapy (CRRT) to replace plasma volume removed by ultrafiltration and to correct electrolyte and acid-base imbalances. They may also be used in case of drug poisoning when CRRT is used to remove dialyable substances.

Warnings and Precautions 
Electrolyte and Volume Abnormalities
PHOXILLUM and PRISMASOL solutions can affect electrolytes and volume and may result in hyperkalemia or hyperphosphatemia. Monitor hemodynamic status and fluid inputs and outputs, potassium, phosphorous, calcium, other electrolytes and acid-base balance throughout the procedure. Abnormalities may be corrected by changing the formulation of replacement solution and/or dialysate, supplementation, or adjusting flow rates appropriately. PHOXILLUM replacement solutions contain hydrogen phosphate, a weak acid that may increase the risk of metabolic acidosis.

Blood Glucose Abnormalities
The use of PRISMASOL and PHOXILLUM replacement solutions can affect blood glucose levels resulting in hypo- or hyper-glycemia depending upon the dextrose content of the replacement solution. Monitor blood glucose levels regularly. Patients may require initiation of or modification of antidiabetic therapy or other corrective measures during treatment.
 
Please see PHOXILLUM and PRISMASOL Solutions full Prescribing Information.
 
 
up button